PDB16 THE COST-UTILITY AND BUDGET IMPACT ANALYSIS OF SITAGLIPTIN (JANUVIA) IN TYPE 2 DIABETES IN POLAND

Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66663-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)66663-6/fulltext
Section Title :
Section Order : 498
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66663-6&doi=10.1016/S1098-3015(10)66663-6
HEOR Topics :
Tags :
Regions :